American Telemedicine Association ATA Nexus 2024
麻豆传媒 is proud to continue its sponsorship of the American Telemedicine Association (ATA) and attend ATA Nexus 2024, exploring The Next Chapter in Virtual Care.
To learn more and register for the event, visit the聽聽and use promo code NEXUS400 at registration for a special discount.
Be sure to stop by聽Booth 401聽in the Expo Hall to meet and reconnect with your 麻豆传媒 contacts.
On Sunday, May 5th at 8:45 a.m. MT, leading digital health leaders will delve into crucial regulatory challenges impacting the digital health industry and provide valuable insights on navigating potential pitfalls and mitigating consequences. Enhance your legal strategy by joining this session 鈥 your legal team will thank you. Hosted by Nate Lacktman, chair of the firm鈥檚 Telemedicine & Digital Health Industry Team and member of ATA鈥檚 Board of Directors, this session will explore:
- 50-State Telehealth Practice Laws: An Assessment of the Pre- and Post-PHE Landscape
- Jacqueline Acosta, Special Counsel
- Get details on a 50-state assessment of telehealth practice laws, including licensure exceptions, allowable modalities, and controlled substance prescribing, all including a comparison of the pre- and post-PHE landscape.
- Jacqueline Acosta, Special Counsel
- Influencers and Social Media Marketing for Digital Health Companies
- Rachel Goodman, Partner
- Jaide Beverly, Associate
- Get the high points on compliance with FDA/FTC regulations and guidelines, state laws on endorsements and testimonials, and fraud and abuse related to influencers and social media marketing for digital health companies. Explore the nuances of the complex landscape of health care regulatory issues surrounding influencers and social media marketing for digital health companies and learn strategies for ensuring ethical and compliant influencer marketing practices.
- Cutting Edge of Digital Health Privacy Law
- Jennifer Hennessy, Partner
- Dive into the rapidly evolving privacy landscape applicable to the digital health industry and its impact on digital advertising, including the interplay between compliance with HIPAA, FTC requirements, and state consumer data privacy laws. Panelists will discuss the requirements for providing patient information under HIPAA, state laws, and the federal information blocking laws as well as the impact of the new 42 CFR Part 2 rules applicable to substance use disorder information.
- Jennifer Hennessy, Partner
- Legal and Reimbursement of Remote Digital Health Technologies (RPM, RTM, Digital Therapeutics, AI)
- T.J. Ferrante, Partner
- One of the biggest hurdles to the widespread adoption of new remote technologies and procedures is payment and coverage policy. As regulators continue to approve new remote technologies for clinical use, understanding of reimbursement is essential for improving patient outcomes while maximizing cost-effectiveness and equity. This session will explore the reimbursement landscape (both current and proposed) of remote digital health technologies such as remote physiologic monitoring (RPM), remote therapeutic monitoring (RTM), digital therapeutics (DTx), and artificial intelligence (AI) and outline how you can make your voice heard in shaping future policy.
- T.J. Ferrante, Partner
- Multistate Telemedicine Prescribing of Controlled Substances
- Nathan Beaver, Partner
- Evan Hellman, Senior Counsel
- Under control: Get a review of the current state of prescribing controlled substances using telemedicine and digital health and join in a discussion about considerations for the future should these rules change.
- Telehealth Joint Ventures, Pilots, and Collaborations
- David Sanders, Partner
- As health care services evolve and technology advances, new options for providing care are emerging, including through joint ventures and strategic alliances. These partnerships create unique issues relative to health care regulatory concerns, brand and reputation management, management and control, and transferability of ownership. Get advice and insight on how to handle these issues upfront.
- David Sanders, Partner
Expanding Realities: AR and VR’s Potential for Virtual Care
On Sunday, May 5, at 3:30 p.m. MT, Nate Lacktman, chair of the firm鈥檚 Telemedicine & Digital Health Industry Team and member of ATA鈥檚 Board of Directors, will join a fireside chat with telemedicine industry leaders to discuss how AR and VR will impact the virtual care space.
Conducting Decentralized Trials Compliantly
On Sunday, May 5, at 12:45 p.m. MT, co-chair of 麻豆传媒鈥檚 Health Care Practice Group and Medical Device Area of Focus, Kyle Faget will join a panel on conducting decentralized clinical trials. Learn about the advantages of using telemedicine when executing clinical trials and the legal and regulatory considerations when utilizing telemedicine in the conduct of clinical trials.
Teamwork, Collaboration, and Intellectual Property: Common Pitfalls and Myths
On Monday, May 6, at 1:50 p.m. MT, Aaron Maguregui, co-chair of 麻豆传媒鈥檚 Data Analytics/Intelligence Area of Focus, will join a curbside session on 鈥渃ode sharing鈥 and it how will impact the digital health landscape.
Learn to protect your health care Intellectual Property (IP). IP law is designed to protect the creations of the mind (e.g. inventions; designs; symbols, names, and images used in business, and literary and artistic works) through patents, copyrights, and trademarks.
Telehealth 101: Implementing Today’s Strategies for Seamless Virtual Care
On Tuesday, May 7, at 10:40 a.m. MT, T.J. Ferrante, vice chair of 麻豆传媒鈥檚 Health Care Practice Group, will join a deep dive session on implementing telehealth strategies for seamless virtual care. Equip yourself with the knowledge and skills needed to not only implement telehealth effectively but also to cultivate a sustainable practice in today’s dynamic health care landscape. Join us as we explore key components, including mapping an integration plan, vendor-health system communication, project management and logistics, market navigation, legal and regulatory considerations, and becoming an effective virtual provider.
